These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10383693)

  • 1. p53 but not bcl-2 is expressed by most cholangiocarcinomas: a study of 28 cases.
    Arora DS; Ramsdale J; Lodge JP; Wyatt JI
    Histopathology; 1999 Jun; 34(6):497-501. PubMed ID: 10383693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas.
    Terada T; Nakanuma Y
    Pathol Int; 1996 Oct; 46(10):764-70. PubMed ID: 8916146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts.
    Washington K; Gottfried MR
    Liver; 1996 Apr; 16(2):99-104. PubMed ID: 8740842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes.
    Hughes NR; Pairojkul C; Royce SG; Clouston A; Bhathal PS
    J Clin Pathol; 2006 Oct; 59(10):1073-8. PubMed ID: 16679351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
    Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
    Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of biliary tract lesions.
    Tan G; Yilmaz A; De Young BR; Behling C; Lehman A; Frankel WL
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):193-7. PubMed ID: 15551730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
    Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
    J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas.
    Della Torre G; Pasquini G; Pilotti S; Alasio L; Civelli E; Cozzi G; Milella M; Salvetti M; Pierotti MA; Severini A
    Diagn Mol Pathol; 2000 Mar; 9(1):41-6. PubMed ID: 10718212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
    Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
    Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma.
    Kang YK; Kim WH; Jang JJ
    Hum Pathol; 2002 Sep; 33(9):877-83. PubMed ID: 12378511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells.
    Feng YJ; Zhang BY; Yao RY; Lu Y
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):418-23. PubMed ID: 22893470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.
    Furubo S; Harada K; Shimonishi T; Katayanagi K; Tsui W; Nakanuma Y
    Histopathology; 1999 Sep; 35(3):230-40. PubMed ID: 10469215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas.
    Karamitopoulou E; Tornillo L; Zlobec I; Cioccari L; Carafa V; Borner M; Schaffner T; Brunner T; Diamantis I; Zimmermann A; Terracciano L
    Am J Clin Pathol; 2008 Nov; 130(5):780-6. PubMed ID: 18854271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
    Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
    Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.
    Charlotte F; L'Herminé A; Martin N; Geleyn Y; Nollet M; Gaulard P; Zafrani ES
    Am J Pathol; 1994 Mar; 144(3):460-5. PubMed ID: 8129031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis.
    Terada T; Nakanuma Y; Sirica AE
    Hum Pathol; 1998 Feb; 29(2):175-80. PubMed ID: 9490278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts.
    Minato H; Nakanuma Y; Terada T
    Histopathology; 1996 May; 28(5):411-9. PubMed ID: 8735716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.